mRNA vaccines saved countless lives during the COVID-19 pandemic and bagged a Nobel prize. Now the technology is being used to develop vaccines against cancer and other life-threatening conditions.

Meanwhile, AI is becoming increasingly integrated into healthcare, while personalised medicine tailored to the precise needs of the individual is poised to transform medicine. Johnson & Johnson is leading the way, and underpinning the approach is the use of digital twins. These are effectively virtual clones that enable medical professionals to diagnose illnesses, practice surgeries, and test the outcome of drug treatments.

One thing's for certain: with a host of new medications and treatments in the pipeline, the future of pharma is looking very exciting.

Liked this? Click the Like button above. And click the Follow button above for more great stories from loveMONEY

Now discover how much countries around the world really spend on healthcare

What's behind the global weight-loss drug explosion?